Study of cerebellar mutism in children with brain tumors
Part of Brain & nervous system, Cancer, Mental health clinical trials.
This study looks at how children with certain brain tumors develop “cerebellar mutism” after surgery or an open biopsy. The goal is to better understand the syndrome and what might help support recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under 18 years old at the time the tumor is first seen on imaging
- Have a tumor located in the cerebellum, the 4th ventricle, or the brainstem
- Be planning to have surgery to remove the tumor or an open biopsy (and later surgeries can also count)
- Have consent from a parent or legal guardian (custodial parent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study tests whether real-time monitoring of brain activity during surgery helps surgeons remove brain tumors more safely while preserving important functions like speech and movement.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This study looks at “brain biomarkers,” meaning brain signals measured on MRI and thinking/learning tests on a computer. It may help researchers understand how brain tumors affect the brain and track changes over time.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
Hear when a new Infratentorial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.